Fortress BiotechFBIO
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 46 institutions reported holding Fortress Biotech Inc. (FBIO) in their 13F filings, down 7 from Q4 2024. 2 opened new positions and 9 sold out. The largest holders were Cambridge Investment Research Advisors, Inc. ($1.6M), Vanguard Group Inc. ($1.2M) and PVG Asset Management Corp. ($737K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Fortress Biotech Inc.
- CUSIP
- 34960Q307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $37K |
| Exits | 9 | $428K |
All 13F filers, Q4 2024 → Q1 2025: 752,615 shares bought and 657,821 shares sold, net +94,794 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 46 holders
| Cambridge Investment Research Advisors, Inc. | 0.01% | Add +8.7% | 1,004,365 | $1.6M |
| Vanguard Group Inc. | 0.00% | Add +20.4% | 752,551 | $1.2M |
| PVG Asset Management Corp. | 3.21% | Add +22.2% | 472,221 | $737K |
| Nantahala Capital Management, LLC | 0.04% | Add +159.3% | 325,520 | $508K |
| Kestra Advisory Services, LLC | 0.00% | Add +29.3% | 292,481 | $456K |
| Envestnet Asset Management Inc. | 0.00% | Add +11.8% | 267,908 | $418K |
| Geode Capital Management, LLC | 0.00% | Add +16.1% | 237,534 | $371K |
| Shikiar Asset Management Inc. | 0.12% | No change | 235,969 | $368K |
| BlackRock, Inc. | 0.00% | Reduce -0.7% | 115,788 | $181K |
| HB Wealth Management, LLC | 0.00% | Add +6.1% | 113,350 | $177K |
| Atria Investments, Inc | 0.00% | Add +13.2% | 100,018 | $156K |
| Corient Private Wealth LP | 0.00% | No change | 96,800 | $151K |
| Acadian Asset Management LLC | 0.00% | Reduce -51.2% | 90,506 | $141K |
| 180 Wealth Advisors, LLC | 0.02% | Add +7.6% | 87,450 | $136K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 61,497 | $96K |
| Integrated Wealth Concepts LLC | 0.00% | No change | 59,400 | $93K |
| Cetera Investment Advisers | 0.00% | Add +105.5% | 46,609 | $73K |
| Weaver Consulting Group | 0.02% | Add +101.8% | 46,417 | $72K |
| PFG Investments, LLC | 0.00% | Add +28.4% | 45,259 | $71K |
| Group One Trading LLC | 0.00% | Add +50.9% | 44,820 | $70K |
| Two Sigma Investments, LP | 0.00% | Reduce -17.1% | 44,799 | $70K |
| State Street Corp. | 0.00% | No change | 43,966 | $69K |
| Choreo, LLC | 0.00% | Reduce -0.4% | 36,250 | $57K |
| Northern Trust Corp. | 0.00% | No change | 35,910 | $56K |
| Renaissance Technologies | 0.00% | Reduce -81.8% | 32,000 | $50K |
| Prudential Financial Inc. | 0.00% | No change | 31,533 | $49K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 30,550 | $48K |
| Osaic Holdings, Inc. | 0.00% | Add +3.1% | 27,345 | $43K |
| Financial Advocates Investment Management | 0.00% | Reduce -1.3% | 23,159 | $36K |
| Titleist Asset Management, LLC | 0.00% | No change | 21,000 | $33K |
| Goldman Sachs Group Inc. | 0.00% | Add +1.5% | 13,030 | $20K |
| Citadel Advisors | 0.00% | Reduce -92.7% | 12,893 | $20K |
| UBS Group AG | 0.00% | Add +7.1% | 12,659 | $20K |
| Virtu Financial LLC | 0.00% | New | 12,464 | $19K |
| Tme Financial, Inc. | 0.02% | New | 11,500 | $18K |
| Morgan Stanley | 0.00% | Add +361.5% | 11,338 | $18K |
| Macquarie Group Ltd. | 0.00% | No change | 6,666 | $10K |
| Ameriflex Group, Inc. | 0.00% | No change | 4,400 | $7K |
| FMR LLC | 0.00% | Reduce -90.6% | 1,950 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 672 | $1K |
| Bank of America Corp. | 0.00% | Add +8.8% | 659 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -89.9% | 515 | $803 |
| BNP Paribas Financial Markets | 0.00% | No change | 376 | $587 |
| Citigroup Inc. | 0.00% | Reduce -93.8% | 193 | $301 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 33 | $51 |
| Wells Fargo & Company | 0.00% | Reduce -99.8% | 16 | $25 |
"% of holder's portfolio" is FBIO's weight in each manager's 13F, not the share of Fortress Biotech Inc. the manager owns.